tiprankstipranks
Trending News
More News >
Medico Remedies Ltd. (IN:MEDICO)
:MEDICO
India Market

Medico Remedies Ltd. (MEDICO) Ratios

Compare
0 Followers

Medico Remedies Ltd. Ratios

IN:MEDICO's free cash flow for Q1 2026 was ₹0.29. For the 2026 fiscal year, IN:MEDICO's free cash flow was decreased by ₹ and operating cash flow was ₹0.07. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
1.62 1.70 1.72 1.72 1.55
Quick Ratio
1.03 1.23 1.34 1.34 1.08
Cash Ratio
<0.01 0.02 <0.01 <0.01 0.02
Solvency Ratio
0.20 0.23 0.32 0.32 0.23
Operating Cash Flow Ratio
0.00 0.09 0.06 0.06 0.20
Short-Term Operating Cash Flow Coverage
0.00 0.35 0.40 0.40 1.01
Net Current Asset Value
₹ 432.98M₹ 393.45M₹ 299.40M₹ 299.40M₹ 209.34M
Leverage Ratios
Debt-to-Assets Ratio
0.09 0.12 0.08 0.08 0.11
Debt-to-Equity Ratio
0.19 0.24 0.15 0.15 0.22
Debt-to-Capital Ratio
0.16 0.19 0.13 0.13 0.18
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 <0.01
Financial Leverage Ratio
2.05 1.92 1.84 1.84 1.99
Debt Service Coverage Ratio
1.17 0.77 1.94 1.94 1.21
Interest Coverage Ratio
14.57 31.36 12.34 12.34 9.24
Debt to Market Cap
0.03 0.03 0.02 0.02 0.01
Interest Debt Per Share
1.67 1.92 1.07 1.07 1.27
Net Debt to EBITDA
0.64 0.91 0.44 0.44 0.65
Profitability Margins
Gross Profit Margin
27.88%28.23%12.09%12.09%25.33%
EBIT Margin
9.38%7.93%8.26%8.26%7.72%
EBITDA Margin
11.14%9.94%12.24%12.24%9.66%
Operating Profit Margin
10.92%24.07%7.01%7.01%4.91%
Pretax Profit Margin
8.80%8.95%7.82%7.82%7.19%
Net Profit Margin
6.61%6.69%5.72%5.72%5.16%
Continuous Operations Profit Margin
6.61%6.69%5.72%5.72%5.16%
Net Income Per EBT
75.12%74.74%73.14%73.14%71.71%
EBT Per EBIT
80.57%37.16%111.50%111.50%146.35%
Return on Assets (ROA)
8.26%8.43%8.62%8.62%8.28%
Return on Equity (ROE)
18.35%16.16%15.83%15.83%16.52%
Return on Capital Employed (ROCE)
28.00%57.82%19.04%19.04%15.03%
Return on Invested Capital (ROIC)
17.74%35.19%12.28%12.28%9.10%
Return on Tangible Assets
8.26%8.43%8.63%8.63%8.29%
Earnings Yield
2.79%2.29%2.02%2.02%1.16%
Efficiency Ratios
Receivables Turnover
2.98 2.64 2.92 2.92 3.89
Payables Turnover
2.31 3.12 4.04 4.04 3.38
Inventory Turnover
2.99 4.05 7.80 7.80 5.32
Fixed Asset Turnover
8.07 6.99 6.78 6.78 6.43
Asset Turnover
1.25 1.26 1.51 1.51 1.61
Working Capital Turnover Ratio
7.91 4.27 5.37 5.37 6.43
Cash Conversion Cycle
86.54 111.36 81.53 81.53 54.53
Days of Sales Outstanding
122.58 138.27 125.01 125.01 93.81
Days of Inventory Outstanding
122.00 90.05 46.81 46.81 68.56
Days of Payables Outstanding
158.04 116.96 90.28 90.28 107.84
Operating Cycle
244.58 228.32 171.81 171.81 162.37
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 0.59 0.32 0.32 0.98
Free Cash Flow Per Share
0.00 0.21 0.02 0.02 0.19
CapEx Per Share
0.00 0.38 0.30 0.30 0.79
Free Cash Flow to Operating Cash Flow
0.00 0.35 0.08 0.08 0.19
Dividend Paid and CapEx Coverage Ratio
0.00 1.54 1.08 1.08 1.24
Capital Expenditure Coverage Ratio
0.00 1.54 1.08 1.08 1.24
Operating Cash Flow Coverage Ratio
0.00 0.33 0.33 0.33 0.84
Operating Cash Flow to Sales Ratio
0.00 0.03 0.02 0.02 0.06
Free Cash Flow Yield
0.00%0.39%0.05%0.05%0.25%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
35.38 43.69 49.45 49.45 86.00
Price-to-Sales (P/S) Ratio
2.34 2.92 2.83 2.83 4.43
Price-to-Book (P/B) Ratio
6.00 7.06 7.83 7.83 14.21
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 258.26 2.01K 2.01K 395.45
Price-to-Operating Cash Flow Ratio
0.00 90.14 152.83 152.83 76.26
Price-to-Earnings Growth (PEG) Ratio
3.69 1.99 3.31 3.31 0.14
Price-to-Fair Value
6.00 7.06 7.83 7.83 14.21
Enterprise Value Multiple
21.67 30.30 23.56 23.56 46.56
Enterprise Value
4.19B 4.55B 4.18B 4.18B 6.32B
EV to EBITDA
21.92 30.30 23.56 23.56 46.56
EV to Sales
2.44 3.01 2.88 2.88 4.50
EV to Free Cash Flow
0.00 266.23 2.04K 2.04K 401.07
EV to Operating Cash Flow
0.00 92.92 155.76 155.76 77.34
Tangible Book Value Per Share
8.06 7.54 6.30 6.30 5.27
Shareholders’ Equity Per Share
8.07 7.55 6.32 6.32 5.28
Tax and Other Ratios
Effective Tax Rate
0.25 0.25 0.27 0.27 0.28
Revenue Per Share
20.72 18.24 17.48 17.48 16.92
Net Income Per Share
1.37 1.22 1.00 1.00 0.87
Tax Burden
0.75 0.75 0.73 0.73 0.72
Interest Burden
0.94 1.13 0.95 0.95 0.93
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
<0.01 0.03 0.04 0.04 0.02
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.48 0.32 0.32 1.13
Currency in INR